https://www.selleckchem.com/pr....oducts/abemaciclib.h
A total of 5 (1.5 %) patients were diagnosed with COVID-19 disease, 1 of whom died from disease complication. Our study provides a unique insight in the decision making for patients with thoracic malignancies in the setting of COVID-19 outbreak, showing how guidelines were implemented in the clinic, and what may be optimized in the clinical practice of thoracic oncology in the future. Our study provides a unique insight in the decision making for patients with thoracic malignancies in the setting of COVID-19 outbreak, showing how gu
Like
Comment
Share
